CHDR

Centre for Human Drug Research is an independent institute specialising in innovative early-stage clinical drug research.

[CHDR @CHDR_NL]

Congratulations to Thomas Buters for being awarded the 2021 British Journal of Clinical Pharmacology prize for the best paper published by early career researchers! Read the paper, or read more about Thomas' work, career and interests here: https://t.co/7l9tZhJD4E

[CHDR @CHDR_NL]

We are pleased to share our 2021 Annual Report, outlining our progress and challenges over the past year, and celebrating the methods and biomarkers developed and implemented by our researchers. Read it here: https://t.co/kfvnE9LTXW

[ASCPT Journal Family @ASCPTjournals]

Meet the #CTSjournal student/trainee spotlight...Get to know Hemme Hijma whose work focuses on analgesic drug development @CHDR_NL

https://t.co/HLh2cXKoHB

[CHDR @CHDR_NL]

We are very proud to announce that Robert Rissmann, Research Director Dermatology at CHDR, has been appointed Professor of Translational Dermatology at @LACDR and CHDR. Read more here: https://t.co/BM0ZPKhQEV

[CHDR @CHDR_NL]

CHDR uses computer-based driving simulators to safely measure the effects of drugs on driving performance, early in their clinical development. Watch this video for a brief overview of our driving simulator: https://t.co/CqleTQaaMg

[CHDR @CHDR_NL]

We are very proud to announce that one of our top scientists, Dr Geert Jan Groeneveld MD, PhD, has been appointed as professor Clinical Neuropharmacology at the Leiden University Medical Center on 01 October 2020! Read more here: https://t.co/KShw3V58M9

[CHDR @CHDR_NL]

In order to systematically quantify subjective effects of new dermatological treatments, we have created the DermaToolbox, a comprehensive set of objective measurements and instruments commonly used for dermatology research: https://t.co/YomoTzm5Ob

[European Journal of Surgical Oncology @ejsotweets]

Intraoperative detection of colorectal and pancreatic liver metastases using SGM-101, a fluorescent antibody targeting CEA @LUMC_Leiden @CHDR_NL

@ESSOnews @OncologyAdvance @isfgs @ManishChandSurg @hpb_so @me4_so @juliomayol

#SurgOnc #HPB #Fluorescence

https://t.co/JN3XSZ5fKa

[CHDR @CHDR_NL]

Geert Jan Groeneveld (CSO/CMO at CHDR) and Albert Dahan (professor of Anesthesiology at @LUMC_Leiden) have received a €1.9 million grant from @ZonMw to study the use of medicinal cannabis in the treatment of neuropathic pain! Read more here: https://t.co/BXHdJU59Bi

[LUMC Leiden @LUMC_Leiden]

Onderzoekers Meta Roestenberg (@vaccinonderzoek) en @ikamerli @CHDR_NL vertelden in het @leidschdagblad over hoe het testen van een kandidaatvaccin tegen het coronavirus op proefpersonen in zijn werk gaat. De belangrijkste punten hebben we hieronder uitgelicht 👇

[CHDR @CHDR_NL]

"We zijn net een kleine week begonnen, en hebben al zo'n 500 aanmeldingen gehad!" Ingrid de Visser - Kamerling, Associate Director CHDR, vertelde bij Omroep West over de grote belangstelling voor het onderzoek naar het coronavaccin van Janssen Vaccines: https://t.co/tktAQZtdei

[Antoni van Leeuwenhoek @hetAVL]

Fluorescent licht maakt prostaatkanker zichtbaar tijdens operatie! Deze nieuwe techniek is toegepast in een studie in samenwerking met het @CHDR_NL en @LUMC_Leiden ➡️ https://t.co/wLVPNQ7gHG #Prostaatkanker #prostaatkankerchirurgie #kankeronderzoek

[CHDR @CHDR_NL]

Koos Burggraaf, CEO CHDR: "We hope this partnership sparks growth and innovation for both teams as we look to the future of human drug research, including advancements in technology and clinical trial design."

[Critical Path Institute (C-Path) @CPathInstitute]

Excited to announce C-Path has partnered with @CHDR_NL, as we continue to expand global collaborations: https://t.co/2mqv59HFeM #CPath #CHDR #globalhealth #drugdevelopment #dataanalytics #drugresearch

[CHDR @CHDR_NL]

CHDR's Advanced Clinical Pharmacology Stipend: an annual amount of up to 10.000 EUR is available to financially support young researchers to develop and further their career in Clinical Pharmacology! https://t.co/tTYLT2bZ7U

[CHDR @CHDR_NL]

We are proud to present our 2019 Annual Report highlighting an important factor that contributed to our success in 2019: our network of collaborators, both in the Netherlands and abroad. Click here to read our full Annual Report: https://t.co/hkJc6TfpE2

[CHDR @CHDR_NL]

We are thrilled to announce that we have restarted screening and some initial clinical work! The past few weeks we have been busy making the required adjustments to our unit & operations, and we are very glad we managed to have a smooth and successful restart last week!

[CHDR @CHDR_NL]

The circumstances created by the COVID-19 measures provided us with the opportunity & time to significantly expand our publication library. Thanks to the dedication of our researchers, we have already published 38 new articles since the beginning of 2020! https://t.co/bUjdFnLwgw

[CHDR @CHDR_NL]

Thanks to our success over the last six years, we are ready to grow beyond our main purpose-built research unit. We've been busy adding to our premises with supplementary office space in the Leiden Bio Science Park. Take a sneak peak at the new offices at the Mendelweg here:

[CHDR @CHDR_NL]

We have joined forces with the Dutch Health Authorities (CCMO) and several expert immunology laboratories & academic partners to enable rapid & efficient start-up times for first-in-human vaccine trials, including COVID-19 trials. Read more here: https://t.co/RE5POx9Sei #beReady

[CHDR @CHDR_NL]

Dr Pieter Siebenga successfully defended his PhD thesis "Characterization and re-evaluation of experimental pain models in healthy subjects" at Leiden University! Pieter conducted his research at our Neurology and Pain group. Read his thesis here: https://t.co/l5QV9Dha0p